Bolt Biotherapeutics, Inc.
BOLT
$5.35
$0.081.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.42% | 23.35% | -0.51% | 8.79% | 8.71% |
| Total Depreciation and Amortization | -19.76% | -12.58% | -6.67% | -3.94% | -1.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -35.05% | -32.84% | -1.46% | 10.49% | -6.70% |
| Change in Net Operating Assets | -92.81% | 0.41% | 60.87% | 14.44% | 53.15% |
| Cash from Operations | 22.90% | 19.64% | 7.91% | 11.85% | 16.51% |
| Capital Expenditure | -53.19% | 76.02% | 79.80% | 80.10% | 87.76% |
| Sale of Property, Plant, and Equipment | 550.68% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.62% | -5.63% | 16.02% | -19.33% | -15.26% |
| Cash from Investing | -9.31% | -3.46% | 18.51% | -18.95% | -14.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -76.76% | -76.76% | -57.31% | -57.31% | -36.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -76.76% | -76.76% | -57.31% | -57.31% | -36.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,815.42% | 148.22% | 139.80% | -304.13% | 117.02% |